Top Markets
#1 MowCat MowCat +26.72%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.90%
#3 Versatize Coin Versatize Coin +16.67%
#4 QuantixAI QuantixAI +15.74%
#5 OriginTrail OriginTrail +12.28%
#6 Pons Pons +11.65%
#7 Wrapped NXM Wrapped NXM +10.43%
#8 Collector Crypt Collector Crypt +9.04%
#9 StonkBroker StonkBroker +8.80%
#10 Siren Siren +8.07%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Clasificación en acciones #20753
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Precio por acción
$2.33
Capitalización bursátil
$122.59M
Cambio (1 día)
0.41%
Cambio (1 año)
110.45%
País
TW
Comercio Great Novel Therapeutics Biotech & Medicals (7427)

Categoría

Healthcare
Ratio P/S de Great Novel Therapeutics Biotech & Medicals (7427)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Great Novel Therapeutics Biotech & Medicals, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Great Novel Therapeutics Biotech & Medicals desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH